SlideShare uma empresa Scribd logo
1 de 1
Baixar para ler offline
 	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  ADVANCED	
  CYTOMETRY	
  SOLUTIONS	
  
	
  
Edwin	
  Walker	
  received	
  his	
  PhD	
  in	
  Cellular	
  Immunology	
  with	
  Dr.	
  Noel	
  Warner	
  at	
  the	
  
University	
  of	
  New	
  Mexico	
  School	
  of	
  Medicine	
  in	
  1982.	
  He	
  subsequently	
  completed	
  a	
  
postdoctoral	
  fellowship	
  in	
  the	
  Flow	
  Cytometry	
  Research	
  and	
  Development	
  Group	
  –	
  
Department	
  of	
  Experimental	
  Pathology	
  under	
  Dr.	
  Carleton	
  Stewart	
  at	
  the	
  Los	
  Alamos	
  National	
  
Laboratory	
  in	
  1984.	
  Following	
  his	
  postdoctoral	
  training	
  Dr.	
  Walker	
  accepted	
  an	
  Assistant	
  
Professor	
  position	
  in	
  the	
  Hematology	
  Oncology	
  Division	
  of	
  the	
  Department	
  of	
  Medicine	
  at	
  
Indiana	
  University	
  –	
  Purdue	
  University,	
  School	
  of	
  Medicine	
  in	
  Indianapolis.	
  He	
  also	
  became	
  
the	
  Director	
  of	
  the	
  Core	
  Flow	
  Cytometry	
  Resource	
  Laboratory	
  for	
  the	
  Medical	
  School.	
  Dr.	
  
Walker	
  became	
  an	
  Associate	
  Professor	
  at	
  Purdue	
  University	
  in	
  1989	
  where	
  he	
  continued	
  to	
  
work	
  on	
  the	
  development	
  of	
  higher	
  order	
  multiparameter	
  flow	
  cytometry	
  procedures	
  for	
  
diagnostic	
  medicine.	
  In	
  1993,	
  he	
  became	
  the	
  Director	
  of	
  the	
  Immunopharmacology	
  
Laboratory	
  and	
  the	
  Director	
  of	
  the	
  Core	
  Flow	
  Cytometry	
  Laboratory	
  at	
  RIBI	
  Immunochem	
  
Research,	
  a	
  biotech	
  company	
  in	
  Hamilton,	
  MT.	
  	
  Following	
  the	
  sale	
  of	
  RIBI	
  Immunochem	
  in	
  
2000,	
  Dr.	
  Walker	
  became	
  the	
  Chief	
  of	
  the	
  Immunological	
  Monitoring	
  Laboratory	
  (IML)	
  at	
  the	
  
Robert	
  W.	
  Franz	
  Cancer	
  Research	
  Center,	
  Earle	
  A	
  Chiles	
  Research	
  Institute,	
  Providence	
  Cancer	
  
Center,	
  in	
  Portland,	
  Oregon.	
  The	
  IML	
  was	
  principally	
  engaged	
  in	
  the	
  development,	
  
optimization,	
  and	
  application	
  of	
  state	
  of	
  the	
  art	
  immunomonitoring	
  procedures,	
  including	
  8-­‐
13	
  parameter	
  higher	
  order	
  polychromatic	
  flow	
  cytometry,	
  for	
  the	
  comprehensive	
  
interrogation	
  of	
  the	
  tumor-­‐specific	
  immune	
  response	
  of	
  cancer	
  patients	
  receiving	
  
immunotherapy.	
  Beginning	
  in	
  2012	
  Dr.	
  Walker’s	
  role	
  in	
  the	
  IML	
  changed	
  to	
  allow	
  more	
  time	
  
for	
  the	
  development	
  and	
  application	
  of	
  polychromatic-­‐flow	
  techniques	
  and	
  multiparameter	
  
data	
  analysis	
  procedures	
  for	
  the	
  study	
  of	
  tumor	
  immunity	
  in	
  cancer	
  immunotherapy	
  patients.	
  
As	
  a	
  Senior	
  Scientist	
  in	
  the	
  IML	
  he	
  directed	
  the	
  application	
  of	
  this	
  technology	
  to	
  the	
  
immunomonitoring	
  of	
  selected	
  investigator	
  initiated	
  immunotherapy	
  trials	
  at	
  Providence	
  
Cancer	
  Center,	
  and	
  for	
  contract	
  research	
  collaborations	
  with	
  the	
  biopharmaceutical	
  industry.	
  	
  
Dr.	
  Walker	
  left	
  Providence	
  in	
  2013	
  and	
  started	
  Advanced	
  Cytometry	
  Solutions	
  LLC	
  to	
  further	
  
promote	
  the	
  implementation	
  of	
  advanced,	
  state	
  of	
  the	
  art	
  polychromatic	
  flow	
  cytometry	
  
technology	
  	
  and	
  assay	
  development	
  in	
  the	
  biopharmaceutical	
  industry.	
  
	
  Edwin	
  B.	
  Walker	
  PhD	
  
Scientific	
  Director	
  
Advanced	
  Cytometry	
  Solutions	
  LLC	
  
13563	
  NW	
  Thompson	
  Rd.	
  
Portland,	
  OR	
  97229	
  
	
  
Phone:	
  (503)	
  327-­‐4976	
  
edwin.b.walker@gmail.com	
  
EDWI	
  	
  	
  	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  
	
  

Mais conteúdo relacionado

Mais procurados

The challenge of gene therapy
The challenge of gene therapyThe challenge of gene therapy
The challenge of gene therapycreativebiolabs11
 
Global radiopharmaceuticals market insight
Global radiopharmaceuticals market insightGlobal radiopharmaceuticals market insight
Global radiopharmaceuticals market insightKuicK Research
 
Experimental Melanoma Vaccine Shows Early Promise
Experimental Melanoma Vaccine Shows Early PromiseExperimental Melanoma Vaccine Shows Early Promise
Experimental Melanoma Vaccine Shows Early Promisefortunatequilt157
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...Medicines Discovery Catapult
 
Drug efficacy, safety and biologics discovery
Drug efficacy, safety and biologics discoveryDrug efficacy, safety and biologics discovery
Drug efficacy, safety and biologics discoverySean Ekins
 
Global Biodiversity Informatics Outlook
Global Biodiversity Informatics OutlookGlobal Biodiversity Informatics Outlook
Global Biodiversity Informatics OutlookGBIF
 
Recent developments in the availability and delivery of biogeochemical datase...
Recent developments in the availability and delivery of biogeochemical datase...Recent developments in the availability and delivery of biogeochemical datase...
Recent developments in the availability and delivery of biogeochemical datase...TERN Australia
 
International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...The King's Fund
 
CV-Europass-20160428-OnyangoOtieno-EN
CV-Europass-20160428-OnyangoOtieno-ENCV-Europass-20160428-OnyangoOtieno-EN
CV-Europass-20160428-OnyangoOtieno-ENKotieno38
 
Apps of array
Apps of arrayApps of array
Apps of arrayghazalndm
 
International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...The King's Fund
 
MDC Connects: Strategies for target and pathway engagement in cellular assays
MDC Connects: Strategies for target and pathway engagement in cellular assaysMDC Connects: Strategies for target and pathway engagement in cellular assays
MDC Connects: Strategies for target and pathway engagement in cellular assaysMedicines Discovery Catapult
 
Biodefense in the Age of Synthetic Biology – Tom Slezak
Biodefense in the Age of Synthetic Biology – Tom SlezakBiodefense in the Age of Synthetic Biology – Tom Slezak
Biodefense in the Age of Synthetic Biology – Tom SlezakCatalyst Biosummit
 
Dekker trog - knowledge engineering in radiation oncology - 2017
Dekker   trog  - knowledge engineering in radiation oncology - 2017Dekker   trog  - knowledge engineering in radiation oncology - 2017
Dekker trog - knowledge engineering in radiation oncology - 2017Andre Dekker
 
InSyBio at Open Coffee Athens CI
InSyBio at Open Coffee Athens CIInSyBio at Open Coffee Athens CI
InSyBio at Open Coffee Athens CIOpen Coffee Greece
 
Emerging technologies 2011 multipactor
Emerging technologies 2011 multipactorEmerging technologies 2011 multipactor
Emerging technologies 2011 multipactorIgor_Kossyi
 
160929 teamscope presentation molecule to business
160929 teamscope presentation molecule to business160929 teamscope presentation molecule to business
160929 teamscope presentation molecule to businessSMBBV
 

Mais procurados (20)

The challenge of gene therapy
The challenge of gene therapyThe challenge of gene therapy
The challenge of gene therapy
 
Global radiopharmaceuticals market insight
Global radiopharmaceuticals market insightGlobal radiopharmaceuticals market insight
Global radiopharmaceuticals market insight
 
Experimental Melanoma Vaccine Shows Early Promise
Experimental Melanoma Vaccine Shows Early PromiseExperimental Melanoma Vaccine Shows Early Promise
Experimental Melanoma Vaccine Shows Early Promise
 
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...
MDC Connects Series 2021 | A Guide to Complex Medicines: Determining Efficacy...
 
Drug efficacy, safety and biologics discovery
Drug efficacy, safety and biologics discoveryDrug efficacy, safety and biologics discovery
Drug efficacy, safety and biologics discovery
 
Global Biodiversity Informatics Outlook
Global Biodiversity Informatics OutlookGlobal Biodiversity Informatics Outlook
Global Biodiversity Informatics Outlook
 
INFO90001 eHealth & biomedical Informatics tools & methods flyer
INFO90001 eHealth & biomedical Informatics tools & methods flyerINFO90001 eHealth & biomedical Informatics tools & methods flyer
INFO90001 eHealth & biomedical Informatics tools & methods flyer
 
Recent developments in the availability and delivery of biogeochemical datase...
Recent developments in the availability and delivery of biogeochemical datase...Recent developments in the availability and delivery of biogeochemical datase...
Recent developments in the availability and delivery of biogeochemical datase...
 
poc4life
poc4lifepoc4life
poc4life
 
International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...
 
CV-Europass-20160428-OnyangoOtieno-EN
CV-Europass-20160428-OnyangoOtieno-ENCV-Europass-20160428-OnyangoOtieno-EN
CV-Europass-20160428-OnyangoOtieno-EN
 
Apps of array
Apps of arrayApps of array
Apps of array
 
UROP_Poster_Hoang_Anh_2016
UROP_Poster_Hoang_Anh_2016UROP_Poster_Hoang_Anh_2016
UROP_Poster_Hoang_Anh_2016
 
International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...International digital health and care congress 2014 - Breakouts: Friday, Sess...
International digital health and care congress 2014 - Breakouts: Friday, Sess...
 
MDC Connects: Strategies for target and pathway engagement in cellular assays
MDC Connects: Strategies for target and pathway engagement in cellular assaysMDC Connects: Strategies for target and pathway engagement in cellular assays
MDC Connects: Strategies for target and pathway engagement in cellular assays
 
Biodefense in the Age of Synthetic Biology – Tom Slezak
Biodefense in the Age of Synthetic Biology – Tom SlezakBiodefense in the Age of Synthetic Biology – Tom Slezak
Biodefense in the Age of Synthetic Biology – Tom Slezak
 
Dekker trog - knowledge engineering in radiation oncology - 2017
Dekker   trog  - knowledge engineering in radiation oncology - 2017Dekker   trog  - knowledge engineering in radiation oncology - 2017
Dekker trog - knowledge engineering in radiation oncology - 2017
 
InSyBio at Open Coffee Athens CI
InSyBio at Open Coffee Athens CIInSyBio at Open Coffee Athens CI
InSyBio at Open Coffee Athens CI
 
Emerging technologies 2011 multipactor
Emerging technologies 2011 multipactorEmerging technologies 2011 multipactor
Emerging technologies 2011 multipactor
 
160929 teamscope presentation molecule to business
160929 teamscope presentation molecule to business160929 teamscope presentation molecule to business
160929 teamscope presentation molecule to business
 

Destaque

Surat lamaran
Surat lamaranSurat lamaran
Surat lamaranbarak85
 
Parts Of Computer with picture
Parts Of Computer with pictureParts Of Computer with picture
Parts Of Computer with pictureNova Babe Torres
 
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...CIARD Movement
 
El ser incapaz
El ser incapazEl ser incapaz
El ser incapazJkamuz
 
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...Mark Verhijde
 
Adat pantang (Karya:MAKARINA)
Adat pantang (Karya:MAKARINA)Adat pantang (Karya:MAKARINA)
Adat pantang (Karya:MAKARINA)Makarina
 
The CIARD RING , a global directory of datasets for agriculture, by Valeria P...
The CIARD RING, a global directory of datasets for agriculture, by Valeria P...The CIARD RING, a global directory of datasets for agriculture, by Valeria P...
The CIARD RING , a global directory of datasets for agriculture, by Valeria P...CIARD Movement
 
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...Vladyslav Zhezherin
 

Destaque (13)

6.c.humanas
6.c.humanas6.c.humanas
6.c.humanas
 
7.naturaleza
7.naturaleza7.naturaleza
7.naturaleza
 
Surat lamaran
Surat lamaranSurat lamaran
Surat lamaran
 
Parts Of Computer with picture
Parts Of Computer with pictureParts Of Computer with picture
Parts Of Computer with picture
 
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...
The agINFRA Linked Data layer by Valeria Pesce, Giovanni l'Abate, Luca Mattei...
 
El ser incapaz
El ser incapazEl ser incapaz
El ser incapaz
 
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...
Mark Verhijde - De Participatiesamenleving is een grote kans voor bedrijven e...
 
Ing cimentaciones
Ing cimentacionesIng cimentaciones
Ing cimentaciones
 
Adat pantang (Karya:MAKARINA)
Adat pantang (Karya:MAKARINA)Adat pantang (Karya:MAKARINA)
Adat pantang (Karya:MAKARINA)
 
Referensi
ReferensiReferensi
Referensi
 
план ф х деятельности (нов)
план ф х деятельности (нов)план ф х деятельности (нов)
план ф х деятельности (нов)
 
The CIARD RING , a global directory of datasets for agriculture, by Valeria P...
The CIARD RING, a global directory of datasets for agriculture, by Valeria P...The CIARD RING, a global directory of datasets for agriculture, by Valeria P...
The CIARD RING , a global directory of datasets for agriculture, by Valeria P...
 
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...
Аналіз імплементації директив ЄС щодо енергоефективності та їх очікуваний впл...
 

Semelhante a ADVANCED CYTOMETRY SOLUTIONS-13

Lior - Bracco Radiology Symposia Booklet
Lior - Bracco Radiology Symposia BookletLior - Bracco Radiology Symposia Booklet
Lior - Bracco Radiology Symposia BookletLior Molvin
 
iOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingeriOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingerssuser9354ce
 
CV J.L. Livermore_Linked In
CV J.L. Livermore_Linked InCV J.L. Livermore_Linked In
CV J.L. Livermore_Linked InJoanne Sharp
 
Immunobiology and new challenges in drug development
Immunobiology and new challenges in drug developmentImmunobiology and new challenges in drug development
Immunobiology and new challenges in drug developmentDr Kurt Sales
 
Candidate 113701 (srg) senior biologist
Candidate 113701 (srg) senior biologistCandidate 113701 (srg) senior biologist
Candidate 113701 (srg) senior biologistJonathan Duckworth
 
Paul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelPaul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelLevi Shapiro
 
Tumour models London 1-3 December 2015 Agenda
Tumour models London 1-3 December 2015 AgendaTumour models London 1-3 December 2015 Agenda
Tumour models London 1-3 December 2015 AgendaDiane McKenna
 
SMi Group's 7th annual Advances in Cell Based Assays conference
SMi Group's 7th annual Advances in Cell Based Assays conferenceSMi Group's 7th annual Advances in Cell Based Assays conference
SMi Group's 7th annual Advances in Cell Based Assays conferenceDale Butler
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical TrialsMichael Passanante
 
3rd annual Tumour Models, London, UK
3rd annual Tumour Models, London, UK3rd annual Tumour Models, London, UK
3rd annual Tumour Models, London, UKDiane McKenna
 
SMi Group's Cancer Vaccines
SMi Group's Cancer VaccinesSMi Group's Cancer Vaccines
SMi Group's Cancer VaccinesDale Butler
 
Big Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramBig Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramMichael Evtushenko
 
Dr. SUE ELIZABETH SHAJAN CV 2016[1]
Dr. SUE ELIZABETH SHAJAN CV 2016[1]Dr. SUE ELIZABETH SHAJAN CV 2016[1]
Dr. SUE ELIZABETH SHAJAN CV 2016[1]sue shajan
 
In-Vitro-Diagnostics- Agenda
In-Vitro-Diagnostics- AgendaIn-Vitro-Diagnostics- Agenda
In-Vitro-Diagnostics- AgendaTony Couch
 

Semelhante a ADVANCED CYTOMETRY SOLUTIONS-13 (20)

Lior - Bracco Radiology Symposia Booklet
Lior - Bracco Radiology Symposia BookletLior - Bracco Radiology Symposia Booklet
Lior - Bracco Radiology Symposia Booklet
 
iOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingeriOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostinger
 
NanoDelivery 2017_TP
NanoDelivery 2017_TPNanoDelivery 2017_TP
NanoDelivery 2017_TP
 
UNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy HighlightsUNC Eshelman School of Pharmacy Highlights
UNC Eshelman School of Pharmacy Highlights
 
CV J.L. Livermore_Linked In
CV J.L. Livermore_Linked InCV J.L. Livermore_Linked In
CV J.L. Livermore_Linked In
 
Immunobiology and new challenges in drug development
Immunobiology and new challenges in drug developmentImmunobiology and new challenges in drug development
Immunobiology and new challenges in drug development
 
Candidate 113701 (srg) senior biologist
Candidate 113701 (srg) senior biologistCandidate 113701 (srg) senior biologist
Candidate 113701 (srg) senior biologist
 
Paul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth IsraelPaul Coplan, VP, Johnson & Johnson_mHealth Israel
Paul Coplan, VP, Johnson & Johnson_mHealth Israel
 
Rahul Resume - RA CV
Rahul Resume - RA CVRahul Resume - RA CV
Rahul Resume - RA CV
 
Tumour models London 1-3 December 2015 Agenda
Tumour models London 1-3 December 2015 AgendaTumour models London 1-3 December 2015 Agenda
Tumour models London 1-3 December 2015 Agenda
 
SMi Group's 7th annual Advances in Cell Based Assays conference
SMi Group's 7th annual Advances in Cell Based Assays conferenceSMi Group's 7th annual Advances in Cell Based Assays conference
SMi Group's 7th annual Advances in Cell Based Assays conference
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical Trials
 
3rd annual Tumour Models, London, UK
3rd annual Tumour Models, London, UK3rd annual Tumour Models, London, UK
3rd annual Tumour Models, London, UK
 
March18 BEST agenda FINAL
March18 BEST agenda FINALMarch18 BEST agenda FINAL
March18 BEST agenda FINAL
 
SMi Group's Cancer Vaccines
SMi Group's Cancer VaccinesSMi Group's Cancer Vaccines
SMi Group's Cancer Vaccines
 
Big Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium ProgramBig Data & Immunotherapeutics Symposium Program
Big Data & Immunotherapeutics Symposium Program
 
journal.pmed.1001903
journal.pmed.1001903journal.pmed.1001903
journal.pmed.1001903
 
DanaM 0116 plus R6
DanaM 0116 plus R6DanaM 0116 plus R6
DanaM 0116 plus R6
 
Dr. SUE ELIZABETH SHAJAN CV 2016[1]
Dr. SUE ELIZABETH SHAJAN CV 2016[1]Dr. SUE ELIZABETH SHAJAN CV 2016[1]
Dr. SUE ELIZABETH SHAJAN CV 2016[1]
 
In-Vitro-Diagnostics- Agenda
In-Vitro-Diagnostics- AgendaIn-Vitro-Diagnostics- Agenda
In-Vitro-Diagnostics- Agenda
 

ADVANCED CYTOMETRY SOLUTIONS-13

  • 1.                          ADVANCED  CYTOMETRY  SOLUTIONS     Edwin  Walker  received  his  PhD  in  Cellular  Immunology  with  Dr.  Noel  Warner  at  the   University  of  New  Mexico  School  of  Medicine  in  1982.  He  subsequently  completed  a   postdoctoral  fellowship  in  the  Flow  Cytometry  Research  and  Development  Group  –   Department  of  Experimental  Pathology  under  Dr.  Carleton  Stewart  at  the  Los  Alamos  National   Laboratory  in  1984.  Following  his  postdoctoral  training  Dr.  Walker  accepted  an  Assistant   Professor  position  in  the  Hematology  Oncology  Division  of  the  Department  of  Medicine  at   Indiana  University  –  Purdue  University,  School  of  Medicine  in  Indianapolis.  He  also  became   the  Director  of  the  Core  Flow  Cytometry  Resource  Laboratory  for  the  Medical  School.  Dr.   Walker  became  an  Associate  Professor  at  Purdue  University  in  1989  where  he  continued  to   work  on  the  development  of  higher  order  multiparameter  flow  cytometry  procedures  for   diagnostic  medicine.  In  1993,  he  became  the  Director  of  the  Immunopharmacology   Laboratory  and  the  Director  of  the  Core  Flow  Cytometry  Laboratory  at  RIBI  Immunochem   Research,  a  biotech  company  in  Hamilton,  MT.    Following  the  sale  of  RIBI  Immunochem  in   2000,  Dr.  Walker  became  the  Chief  of  the  Immunological  Monitoring  Laboratory  (IML)  at  the   Robert  W.  Franz  Cancer  Research  Center,  Earle  A  Chiles  Research  Institute,  Providence  Cancer   Center,  in  Portland,  Oregon.  The  IML  was  principally  engaged  in  the  development,   optimization,  and  application  of  state  of  the  art  immunomonitoring  procedures,  including  8-­‐ 13  parameter  higher  order  polychromatic  flow  cytometry,  for  the  comprehensive   interrogation  of  the  tumor-­‐specific  immune  response  of  cancer  patients  receiving   immunotherapy.  Beginning  in  2012  Dr.  Walker’s  role  in  the  IML  changed  to  allow  more  time   for  the  development  and  application  of  polychromatic-­‐flow  techniques  and  multiparameter   data  analysis  procedures  for  the  study  of  tumor  immunity  in  cancer  immunotherapy  patients.   As  a  Senior  Scientist  in  the  IML  he  directed  the  application  of  this  technology  to  the   immunomonitoring  of  selected  investigator  initiated  immunotherapy  trials  at  Providence   Cancer  Center,  and  for  contract  research  collaborations  with  the  biopharmaceutical  industry.     Dr.  Walker  left  Providence  in  2013  and  started  Advanced  Cytometry  Solutions  LLC  to  further   promote  the  implementation  of  advanced,  state  of  the  art  polychromatic  flow  cytometry   technology    and  assay  development  in  the  biopharmaceutical  industry.    Edwin  B.  Walker  PhD   Scientific  Director   Advanced  Cytometry  Solutions  LLC   13563  NW  Thompson  Rd.   Portland,  OR  97229     Phone:  (503)  327-­‐4976   edwin.b.walker@gmail.com   EDWI